NOD2/CARD15 gene mutations in patients with familial Mediterranean fever

Seminars in Arthritis and Rheumatism

Volumn 42, Issue 1, 2012, Pages 84-88

  Berkun, Yackov ^a   Karban, Amir ^b   Padeh, Shai ^c,f   Pras, Elon ^d,f   Shinar, Yael ^e,f   Lidar, Merav ^e,f   Livneh, Avi ^e,f   Bujanover, Yoram ^f,g  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^e HELLER INSTITUTE OF MEDICAL RESEARCH   (Israel)

^f TEL AVIV UNIVERSITY   (Israel)

^g Edmond and Lily Safra Children's Hospital   (Israel)

Author keywords

Autoinflammatory; Children; Familial Mediterranean fever; MEFV; Mutations; NOD2 CARD15; Phenotype

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; COLCHICINE;

ARTICLE; CARD15 GENE; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; ERYSIPELAS; ERYTHEMA; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE; GENE MUTATION; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NOD2 GENE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCROTUM DISORDER;

ACUTE DISEASE; CHILD, PRESCHOOL; COHORT STUDIES; COLCHICINE; DRUG RESISTANCE; ERYTHEMA; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; PROGNOSIS; SCROTUM; SEVERITY OF ILLNESS INDEX;

EID: 84864109270     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2011.12.002     Document Type: Article

References (31)

1. Padeh S., Berkun Y. Auto-inflammatory fever syndromes. Rheum Dis Clin North Am 2007, 33:585-623.
2. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell 1997, 90:797-807.
3. Berkun Y., Ben-Chetrit E. Pyrin and cryopyrin-similar domain sequence but opposite inflammatory consequence. Clin Exp Rheumatol 2007, 25:S6-S8.
4. Shinar Y., Livneh A., Langevitz P., Zaks N., Aksentijevich I., Koziol D.E., et al. Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever. J Rheumatol 2000, 27:1703-1707.
5. Gershoni-Baruch R., Brik R., Shinawi M., Livneh A. The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever. Eur J Hum Genet 2002, 10:145-149.
6. Marek-Yagel D., Berkun Y., Padeh S., Abu A., Reznik-Wolf H., Livneh A., et al. Clinical disease among patients heterozygous for familial Mediterranean fever. Arthritis Rheum 2009, 60:1862-1866.
7. Kogan A., Shinar Y., Lidar M., Revivo A., Langevitz P., Padeh S., et al. Common MEFV mutations among Jewish ethnic groups in Israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state. Am J Med Genet 2001, 102:272-276.
8. Touitou I., Picot M.C., Domingo C., Notarnicola C., Cattan D., Demaille J., et al. The MICA region determines the first modifier locus in familial Mediterranean fever. Arthritis Rheum 2001, 44:163-169.
9. Marek-Yagel D., Berkun Y., Padeh S., Lidar M., Shinar Y., Bar-Joseph I., et al. Role of the R92Q TNFRSF1A mutation in patients with familial Mediterranean fever. Arthritis Care Res (Hoboken) 2010, 62:1294-1298.
10. Gershoni-Baruch R., Brik R., Zacks N., Shinawi M., Lidar M., Livneh A. The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum 2003, 48:1149-1155.
11. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411:599-603.
12. Karban A., Eliakim R., Brant S.R. Genetics of inflammatory bowel disease. Isr Med Assoc J 2002, 4:798-802.
13. Lesage S., Zouali H., Cezard J.P., Colombel J.F., Belaiche J., Almer S., et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002, 70:845-857.
14. Karban A., Waterman M., Panhuysen C.I., Pollak R.D., Nesher S., Datta L., et al. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease. Am J Gastroenterol 2004, 99:1134-1140.
15. Fidder H., Chowers Y., Ackerman Z., Pollak R.D., Crusius J.B., Livneh A., et al. The familial Mediterranean fever (MEVF) gene as a modifier of Crohn's disease. Am J Gastroenterol 2005, 100:338-343.
16. Karban A., Dagan E., Eliakim R., Herman A., Nesher S., Weiss B., et al. Prevalence and significance of mutations in the familial Mediterranean fever gene in patients with Crohn's disease. Genes Immun 2005, 6:134-139.
17. Livneh A., Langevitz P., Zemer D., Zaks N., Kees S., Lidar T., et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997, 40:1879-1885.
18. Uslu N., Yuce A., Demir H., Saltik-Temizel I.N., Usta Y., Yilmaz E., et al. The association of inflammatory bowel disease and Mediterranean fever gene (MEFV) mutations in Turkish children. Dig Dis Sci 2010, 55:3488-3494.
19. Cattan D., Notarnicola C., Molinari N., Touitou I. Inflammatory bowel disease in non-Ashkenazi Jews with familial Mediterranean fever. Lancet 2000, 355:378-379.
20. Kuloglu Z., Kansu A., Ustundag G., Birsin Ozcakar Z., Ensari A., Ekim M. An infant with severe refractory Crohn's disease and homozygous MEFV mutation who dramatically responded to colchicine. Rheumatol Int 2010, [Epub ahead of print].
21. Fidder H.H., Chowers Y., Lidar M., Sternberg M., Langevitz P., Livneh A. Crohn disease in patients with familial Mediterranean fever. Medicine (Baltimore) 2002, 81:411-416.
22. Miceli-Richard C., Zouali H., Lesage S., Thomas G., Hugot J.P., Said-Nahal R., et al. CARD15/NOD2 analyses in spondylarthropathy. Arthritis Rheum 2002, 46:1405-1406.
23. Ferreiros-Vidal I., Barros F., Pablos J.L., Carracedo A., Gomez-Reino J.J., Gonzalez A. CARD15/NOD2 analysis in rheumatoid arthritis susceptibility. Rheumatology (Oxford) 2003, 42:1380-1382.
24. Ferreiros-Vidal I., Garcia-Meijide J., Carreira P., Barros F., Carracedo A., Gomez-Reino J.J., et al. The three most common CARD15 mutations associated with Crohn's disease and the chromosome 16 susceptibility locus for systemic lupus erythematosus. Rheumatology (Oxford) 2003, 42:570-574.
25. Kappen J.H., Wallace G.R., Stolk L., Rivadeneira F., Uitterlinden A.G., van Daele P.L., et al. Low prevalence of NOD2 SNPs in Behcet's disease suggests protective association in Caucasians. Rheumatology (Oxford) 2009, 48:1375-1377.
26. Milman N., Nielsen O.H., Hviid T.V., Fenger K. CARD15 single nucleotide polymorphisms 8, 12 and 13 are not increased in ethnic Danes with sarcoidosis. Respiration 2007, 74:76-79.
27. Rahman P., Bartlett S., Siannis F., Pellett F.J., Farewell V.T., Peddle L., et al. CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis. Am J Hum Genet 2003, 73:677-681.
28. Uyar F.A., Saruhan-Direskeneli G., Gul A. Common Crohn's disease-predisposing variants of the CARD15/NOD2 gene are not associated with Behcet's disease in Turkey. Clin Exp Rheumatol 2004, 22:S50-S52.
29. Sawcer S., Maranian M., Hensiek A., Roxburgh R., Gray J., Compston A. Crohn's associated NOD2 gene variants are not involved in determining susceptibility to multiple sclerosis. J Neurol Neurosurg Psychiatry 2003, 74:1157.
30. Schurmann M., Valentonyte R., Hampe J., Muller-Quernheim J., Schwinger E., Schreiber S. CARD15 gene mutations in sarcoidosis. Eur Respir J 2003, 22:748-754.
31. Dagan E., Gershoni-Baruch R., Khatib I., Mori A., Brik R. MEFV, TNF1rA, CARD15 and NLRP3 mutation analysis in PFAPA. Rheumatol Int 2010, 30:633-636.